Lista de obras - Ji Zhu - Dominio Público Uruguay

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

artículo científico publicado en 2013

Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study

artículo científico publicado en 2014

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients ⬇️

artículo científico publicado el 15 de diciembre de 2010

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 11 genotype

scientific article published on 06 June 2019

Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit

scientific article published on 10 March 2008

Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies.

artículo científico publicado en 2016

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

artículo científico publicado en 2014

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

artículo científico publicado en 2015

CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients

artículo científico publicado en 2014

Can tumor regression grade influence survival outcome in ypT3 rectal cancer?

artículo científico publicado en 2015

CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial.

scientific article published on December 2016

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy

artículo científico publicado en 2016

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

artículo científico publicado en 2014

Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

artículo científico publicado en 2013

Electroacupuncture treatment for pancreatic cancer pain: a randomized controlled trial

artículo científico publicado en 2013

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy.

artículo científico publicado en 2015

Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer

artículo científico publicado en 2017

Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis ⬇️

artículo científico publicado el 19 de febrero de 2013

Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older.

artículo científico publicado en 2015

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation

artículo científico publicado en 2015

Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?

artículo científico publicado en 2017

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)

scientific article published on 29 November 2019

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

artículo científico

MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.

artículo científico publicado en 2014

Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer

artículo científico publicado en 2020

Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.

artículo científico publicado en 2016

Overactivated neddylation pathway as a therapeutic target in lung cancer.

artículo científico publicado en 2014

Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design

artículo científico publicado en 2017

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma

artículo científico publicado en 2013

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction

artículo científico publicado en 2013

Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer

artículo científico publicado en 2008

Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.

artículo científico publicado en 2015

Problematic Landmark Analysis Has Led to a Problematic Conclusion

artículo científico publicado en 2017

Prognostic Inflammatory Index Based on Preoperative Peripheral Blood for Predicting the Prognosis of Colorectal Cancer Patients

artículo científico publicado en 2020

Prognostic risk factors in patients with bone metastasis from colorectal cancer

artículo científico publicado en 2016

Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

artículo científico publicado en 2008

Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme

artículo científico publicado en 2015

Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis.

artículo científico publicado en 2017

Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases

artículo científico publicado en 2016

Sex, Race, and Age Disparities in the Improvement of Survival for Gastrointestinal Cancer over Time.

artículo científico publicado en 2016

Short-course radiotherapy with delayed surgery for rectal cancer

T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients

artículo científico publicado en 2017

TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy

artículo científico publicado en 2015

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.

artículo científico publicado en 2013

Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.

artículo científico publicado en 2013

Tumour diameter is a predictor of mesorectal and mesenteric lymph node metastases in anorectal melanoma ⬇️

artículo científico publicado el 1 de septiembre de 2013

Whole brain radiotherapy for non-small cell lung cancer

artículo científico publicado en 2017

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer

artículo científico publicado en 2015

Lista de obras de Ji Zhu

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients ⬇️

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 *1*1 genotype

Application of active breathing control in 3-dimensional conformal radiation therapy for hepatocellular carcinoma: the feasibility and benefit

Association between dietary nitrate and nitrite intake and sitespecific cancer risk: evidence from observational studies.

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

CXCL10 mRNA expression predicts response to neoadjuvant chemoradiotherapy in rectal cancer patients

Can tumor regression grade influence survival outcome in ypT3 rectal cancer?

CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial.

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study

Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Electroacupuncture treatment for pancreatic cancer pain: a randomized controlled trial

Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy.

Genotype-driven phase I study of weekly irinotecan in combination with capecitabine-based neoadjuvant chemoradiation for locally advanced rectal cancer

Impact of Lymph Node Ratio on the Survival of Patients with Hypopharyngeal Squamous Cell Carcinoma: A Population-Based Analysis ⬇️

Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older.

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation

Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?

Long-course neoadjuvant chemoradiotherapy with versus without a concomitant boost in locally advanced rectal cancer: a randomized, multicenter, phase II trial (FDRT-002)

Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.

Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by UGT1A1 Status in Patients With Locally Advanced Rectal Cancer

Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.

Overactivated neddylation pathway as a therapeutic target in lung cancer.

Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction

Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer

Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.

Problematic Landmark Analysis Has Led to a Problematic Conclusion

Prognostic Inflammatory Index Based on Preoperative Peripheral Blood for Predicting the Prognosis of Colorectal Cancer Patients

Prognostic risk factors in patients with bone metastasis from colorectal cancer

Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.

Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme

Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis.

Role of pelvic radiotherapy for locally advanced rectal cancer and synchronous unresectable distant metastases

Sex, Race, and Age Disparities in the Improvement of Survival for Gastrointestinal Cancer over Time.

Short-course radiotherapy with delayed surgery for rectal cancer

T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients

TNF rs1799964 as a Predictive Factor of Acute Toxicities in Chinese Rectal Cancer Patients Treated With Chemoradiotherapy

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.

Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.

Tumour diameter is a predictor of mesorectal and mesenteric lymph node metastases in anorectal melanoma ⬇️

Whole brain radiotherapy for non-small cell lung cancer

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer

An expansion study of genotype-driven weekly irinotecan and capecitabine in combination with neoadjuvant radiotherapy for locally advanced rectal cancer with UGT1A1 11 genotype